143 related articles for article (PubMed ID: 18026578)
1. Endoscopic pH monitoring for patients with suspected or refractory gastroesophageal reflux disease.
Turner BG; Saltzman JR; Hua L; Maurer R; Feldman N; Carr-Locke DL; Burakoff R; Liu JJ
Can J Gastroenterol; 2007 Nov; 21(11):737-41. PubMed ID: 18026578
[TBL] [Abstract][Full Text] [Related]
2. Impact of prolonged 48-h wireless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptoms and reflux episodes.
Domingues GR; Moraes-Filho JP; Domingues AG
Arq Gastroenterol; 2011; 48(1):24-9. PubMed ID: 21537538
[TBL] [Abstract][Full Text] [Related]
3. Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring.
Bansal A; Wani S; Rastogi A; Rastogi K; Goyal A; Hall S; Singh V; Higbee A; Sharma P
Am J Gastroenterol; 2009 Dec; 104(12):2918-25. PubMed ID: 19755975
[TBL] [Abstract][Full Text] [Related]
4. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico.
Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA
Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility and tolerability of JSPH-1 wireless esophageal pH monitoring system.
Li JN; Liu CL; Tao XH
BMC Gastroenterol; 2013 Jan; 13():10. PubMed ID: 23317032
[TBL] [Abstract][Full Text] [Related]
6. Wireless esophageal pH capsule for patients with gastroesophageal reflux disease: a multicenter clinical study.
Yang XJ; Gan T; Wang L; Liao Z; Tao XH; Shen W; Zhao XY
World J Gastroenterol; 2014 Oct; 20(40):14865-74. PubMed ID: 25356046
[TBL] [Abstract][Full Text] [Related]
7. 24 Versus 48-hour bravo pH monitoring.
Chander B; Hanley-Williams N; Deng Y; Sheth A
J Clin Gastroenterol; 2012 Mar; 46(3):197-200. PubMed ID: 21959323
[TBL] [Abstract][Full Text] [Related]
8. Wireless pH capsule--yield in clinical practice.
Roman S; Mion F; Zerbib F; Benamouzig R; Letard JC; Bruley des Varannes S
Endoscopy; 2012 Mar; 44(3):270-6. PubMed ID: 22275050
[TBL] [Abstract][Full Text] [Related]
9. Long-term wireless pH monitoring of the distal esophagus: prolonging the test beyond 48 hours is unnecessary and may be misleading.
Capovilla G; Salvador R; Spadotto L; Voltarel G; Pesenti E; Perazzolo A; Nicoletti L; Merigliano S; Costantini M
Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859392
[TBL] [Abstract][Full Text] [Related]
10. [Successful esophageal pH monitoring with Bravo capsule in patients with gastroesophageal reflux disease].
Valdovinos Díaz MA; Remes Troche JM; Ruiz Aguilar JC; Schmulson MJ; Valdovinos-Andraca F
Rev Gastroenterol Mex; 2004; 69(2):62-8. PubMed ID: 15757153
[TBL] [Abstract][Full Text] [Related]
11. Ninety-Six Hour Wireless Esophageal pH Study in Patients with GERD Shows that Restrictive Diet Reduces Esophageal Acid Exposure.
Triadafilopoulos G; Korzilius JW; Zikos T; Sonu I; Fernandez-Becker NQ; Nguyen L; Clarke JO
Dig Dis Sci; 2020 Aug; 65(8):2331-2344. PubMed ID: 31734874
[TBL] [Abstract][Full Text] [Related]
12. Interference with daily activities and major adverse events during esophageal pH monitoring with bravo wireless capsule versus conventional intranasal catheter: a systematic review of randomized controlled trials.
Iluyomade A; Olowoyeye A; Fadahunsi O; Thomas L; Libend CN; Ragunathan K; Fenster J; Vignesh S
Dis Esophagus; 2017 Feb; 30(3):1-9. PubMed ID: 26952638
[TBL] [Abstract][Full Text] [Related]
13. Comparison of esophageal acid exposure at 1 cm and 6 cm above the squamocolumnar junction using the Bravo pH monitoring system.
Pandolfino JE; Lee TJ; Schreiner MA; Zhang Q; Roth MP; Kahrilas PJ
Dis Esophagus; 2006; 19(3):177-82. PubMed ID: 16722995
[TBL] [Abstract][Full Text] [Related]
14. Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?
Vardar R; Keskin M
Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S16-S21. PubMed ID: 29199161
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of two modes of gastroesophageal reflux measuring: conventional esophageal pH monitoring and wireless pH monitoring.
Azzam RS; Sallum RA; Brandão JF; Navarro-Rodriguez T; Nasi A
Arq Gastroenterol; 2012; 49(2):107-12. PubMed ID: 22766996
[TBL] [Abstract][Full Text] [Related]
16. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
17. Reflux monitoring.
Stein E; Katz PO
Rev Gastroenterol Disord; 2009; 9(2):E54-62. PubMed ID: 19668126
[TBL] [Abstract][Full Text] [Related]
18. Wireless esophageal pH monitoring: new technique means new questions.
Bhat YM; McGrath KM; Bielefeldt K
J Clin Gastroenterol; 2006 Feb; 40(2):116-21. PubMed ID: 16394871
[TBL] [Abstract][Full Text] [Related]
19. An analysis of 342 patients with refractory gastroesophageal reflux disease symptoms using questionnaires, high-resolution manometry, and impedance-pH monitoring.
Wang F; Li P; Ji GZ; Miao L; Fan Z; You S; Pan X; Chen X
Medicine (Baltimore); 2017 Feb; 96(5):e5906. PubMed ID: 28151867
[TBL] [Abstract][Full Text] [Related]
20. Impedance-pH monitoring on medications does not reliably confirm the presence of gastroesophageal reflux disease in patients referred for antireflux surgery.
Ward MA; Dunst CM; Teitelbaum EN; Halpin VJ; Reavis KM; Swanström LL; DeMeester SR
Surg Endosc; 2018 Feb; 32(2):889-894. PubMed ID: 28779252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
